18-β-glycyrrhetinic acid facilitates nuclear-mitochondrial communications to alleviate oxidative stress through HMGB1-cGAS-Mul1 axis in tendinopathy
Journal of Translational Medicine · 2026
DOI: 10.1186/s12967-026-08091-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Medicine, 2026. Verfasst von Yuan-Yuan Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Oxidative Stress, Glycyrrhetinic Acid, HMGB1 Protein, Mitochondria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Leading Program for First Class Disciplines at Nanjing University of Traditional Chinese Medicine, National Key Laboratory of Traditional Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacturing Technology Research Innovation Project.
Abstract (Originalsprache)
BACKGROUND: Tendinopathy is a prevalent orthopaedic condition characterized by disrupted tendon homeostasis, with oxidative stress being a key contributing mechanism. Although the natural compound 18-β-Glycyrrhetinic acid (GA) exhibits antioxidant properties and is a therapeutic candidate for tendinopathy, its precise molecular mechanism remains unclear. This study aimed to elucidate how GA alleviates tendinopathy, with a focus on its role in regulating the HMGB1-cGAS-STING axis and NLRP3 inflammasome activation in the context of oxidative stress. METHODS: We employed single-cell RNA sequencing (scRNA-seq) of clinical samples, proteomics of animal tissues, and comprehensive pharmacological assays to investigate the mechanisms of tendinopathy. Furthermore, the rat tendinopathy model and H2O2-induced oxidative stress model of tendon stem cells (TSCs) were used to validate the protective effects of GA. RESULTS: We found that GA significantly reduced oxidative stress and subsequent inflammation, thereby mitigating collagen disruption in rats with tendinopathy. Notably, scRNA-seq revealed that the proportion of TSCs increased significantly during tendinopathy, which were particularly susceptible to reactive oxygen species (ROS). TSCs from oxidative damage and inhibited activation of the NLRP3 inflammasome by suppressing the cGAS-STING pathway. Mechanistically, GA promoted cGAS degradation by enhancing its interaction with the mitochondrial E3 ubiquitin ligase Mul1. This effect was mediated through high-mobility group box 1 (HMGB1), as GA disrupted the HMGB1-cGAS interaction. Specifically, GA induced methylation of HMGB1 at lysine 43, a modification essential for its activity. This methylation was catalyzed by the methyltransferase DOT1L, which was upregulated and directly bound by GA. Collectively, GA alleviates tendinopathy by targeting the DOT1L-HMGB1-cGAS axis to resolve oxidative stress and inflammation. CONCLUSION: Collectively, our findings provide new insights into how oxidative stress accelerates tendinopathy progression. Moreover, they delineate the mechanism by which GA in mitigates oxidative damage and inflammation in TSCs by inhibiting the co-localization of HMGB1 and cGAS. Overall, this study offers scientific support for further developing GA as a promising therapeutic agent for tendinopathy treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing, China.
- Jiangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia Media, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Pharmacy, Nantong Third People's Hospital, Nantong, China.
- State Key Laboratory of Pharmaceutical Biotechnology, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.
- Jiangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia Media, Nanjing University of Chinese Medicine, Nanjing, China. jjshao@njucm.edu.cn.
- Jiangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia Media, Nanjing University of Chinese Medicine, Nanjing, China. zilizhang@njucm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Leading Program for First Class Disciplines at Nanjing University of Traditional Chinese Medicine
- National Key Laboratory of Traditional Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacturing Technology Research Innovation Project
- Traditional Chinese Medicine Cancer Poison Disclosure and Leading Project
- Natural Science Foundation of Jiangsu Province
- general Project of the Natural Science Research of Jiangsu Higher Education Institutions
- Program of Jinling hospital
Zitieren
APA
Gao, Y. Y., Sun, W. S., Sun, Z. Y., Wang, J. R., Lv, Z. Y., Li, Y. J., Tian, H. Y., Bao, Z. Y., Qiu, X. R., Wang, Z., Zheng, S. Z., Shao, J. J., Zhang, Z. L., & Meng, J. (2026). 18-β-glycyrrhetinic acid facilitates nuclear-mitochondrial communications to alleviate oxidative stress through HMGB1-cGAS-Mul1 axis in tendinopathy. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-08091-4
Vancouver
Gao YY, Sun WS, Sun ZY, Wang JR, Lv ZY, Li YJ, et al. 18-β-glycyrrhetinic acid facilitates nuclear-mitochondrial communications to alleviate oxidative stress through HMGB1-cGAS-Mul1 axis in tendinopathy. Journal of Translational Medicine. 2026. doi:10.1186/s12967-026-08091-4
BibTeX
@article{Gao2026,
author = {Gao, Yuan-Yuan and Sun, Wen-Shuang and Sun, Zi-Ying and Wang, Jun-Rui and Lv, Zhong-Yang and Li, Yu-Jia and Tian, Hao-Yuan and Bao, Zheng-Yang and Qiu, Xin-Ran and Wang, Zheng and Zheng, Shi-Zhong and Shao, Jiang-Juan and Zhang, Zi-Li and Meng, Jia},
title = {18-β-glycyrrhetinic acid facilitates nuclear-mitochondrial communications to alleviate oxidative stress through HMGB1-cGAS-Mul1 axis in tendinopathy},
journal = {Journal of Translational Medicine},
year = {2026},
doi = {10.1186/s12967-026-08091-4}
}
EUVIMED